2022 - Research.com Best Female Scientist Award
2022 - Research.com Microbiology in Australia Leader Award
The scientist’s investigation covers issues in Internal medicine, Gynecology, Vaccination, Cervical cancer and Immunology. Her studies deal with areas such as Antibiotics and Vaccine efficacy as well as Internal medicine. Her Gynecology research is multidisciplinary, incorporating perspectives in Chlamydia, Men who have sex with men, Placebo, Obstetrics and Gonorrhea.
Her Vaccination study integrates concerns from other disciplines, such as Young adult, Papillomaviridae, Immunization, Genital warts and Cohort. The study incorporates disciplines such as Gardnerella vaginalis, Disease, Papillomavirus Vaccines and Gardasil in addition to Immunology. Her research integrates issues of Colposcopy and Intraepithelial neoplasia in her study of Cervical intraepithelial neoplasia.
Her primary areas of study are Gynecology, Internal medicine, Cervical cancer, Vaccination and Virology. Her Gynecology research integrates issues from Young adult, Papillomaviridae, HPV infection and Obstetrics. Her Internal medicine research includes themes of Men who have sex with men, Oncology and Genotype.
Her Cervical cancer study results in a more complete grasp of Cancer. The subject of her Vaccination research is within the realm of Immunology. Her research in Virology intersects with topics in Polymerase chain reaction and Microbiology.
Suzanne M. Garland focuses on Internal medicine, Vaccination, Cervical cancer, Mycoplasma genitalium and Papillomaviridae. Suzanne M. Garland has researched Internal medicine in several fields, including Gastroenterology, Chlamydia and Men who have sex with men. Her study on Vaccination is covered under Immunology.
Her study in Cervical cancer is interdisciplinary in nature, drawing from both Public health, Oncology, Family medicine and Cervix. Suzanne M. Garland combines subjects such as Genital warts and Papillomavirus Vaccines with her study of Papillomaviridae. Her Anal cancer research includes themes of Anal canal, Squamous intraepithelial lesion, Anoscopy and Incidence.
Her primary areas of investigation include Internal medicine, Papillomaviridae, Cervical cancer, Vaccination and Incidence. Her research in Internal medicine intersects with topics in Men who have sex with men, Gastroenterology, Placebo, Mycoplasma genitalium and Azithromycin. The Papillomaviridae study combines topics in areas such as Immunohistochemistry, Genotyping, Head and neck cancer and Cervical intraepithelial neoplasia.
Her studies deal with areas such as Genotype, Vaccine efficacy, Family medicine and Cervix as well as Cervical cancer. Her Vaccination research is multidisciplinary, relying on both Human Papilloma Virus Vaccine, Human papillomavirus, Young adult, Genital warts and HPV infection. In her study, Anoscopy is inextricably linked to Anal cancer, which falls within the broad field of Incidence.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.
Suzanne M. Garland;Suzanne M. Garland;Mauricio Hernandez-Avila;Cosette M. Wheeler;Gonzalo Perez.
The New England Journal of Medicine (2007)
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
Silvia de Sanjose;Wim G.V. Quint;Laia Alemany;Daan T. Geraets.
Lancet Oncology (2010)
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.
J. Paavonen;P. Naud;J. Salmeron;C. M. Wheeler.
The Lancet (2009)
A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
Elmar A. Joura;Anna R. Giuliano;Ole-Erik Iversen;Celine Bouchard.
The New England Journal of Medicine (2015)
Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis
Dorothy A Machalek;Mary Poynten;Fengyi Jin;Christopher K Fairley.
Lancet Oncology (2012)
Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
Matti Lehtinen;Jorma Paavonen;Cosette M. Wheeler;Unnop Jaisamrarn.
Lancet Oncology (2012)
Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials
Elmar A Joura;Sepp Leodolter;Mauricio Hernandez-Avila;Cosette M Wheeler.
The Lancet (2007)
A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines
John T. Schiller;Xavier Castellsagué;Suzanne M. Garland.
Vaccine (2012)
High Recurrence Rates of Bacterial Vaginosis over the Course of 12 Months after Oral Metronidazole Therapy and Factors Associated with Recurrence
Catriona S. Bradshaw;Anna N. Morton;Jane Hocking;Suzanne M. Garland.
The Journal of Infectious Diseases (2006)
Comprehensive control of human papillomavirus infections and related diseases.
F. Xavier Bosch;Thomas R. Broker;David Forman;Anna Barbara Moscicki.
Vaccine (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Royal Women's Hospital
Monash University
Monash University
Royal Melbourne Hospital
UNSW Sydney
University of Melbourne
University of Helsinki
University of New Mexico
UNSW Sydney
International Gynaecological Cancer Society
University of Catania
Max Planck Society
MRC Laboratory of Molecular Biology
University of Oregon
Tohoku University
University of Michigan–Ann Arbor
University of Dundee
University of British Columbia
University of Sydney
University College London
Washington University in St. Louis
Charité - University Medicine Berlin
Central Queensland University
University of London
University of Manchester
Georgetown University